New antibacterial drug site comes on-line in Urals; outside world interested

Print 15 June 2015
Marchmont Innovation News

A production site to manufacture a new antibacterial drug has opened in the Sverdlovsk region, in the Urals, the Yekaterinburg-based editorial bureau of the Russian daily Delovoy Kvartal  reported . 

It’s the Ural Nanotech Center, part of the Ural Biomed Clucter, that has reportedly developed the new drug. The solution designated “Dezitol” is a composition that dries after administering and forms a polymer antibacterial kind of film. The coating is believed to be able to kill germs that are located on or can possibly get onto an area being treated, thus dramatically reducing the risk of developing an infection. 

The developers have launched the serial production of two versions of the drug. One is Dezitol C, which can be used to treat rooms; the other is Dezitol B, meant for treating the skin surface. 

The production site opened to manufacture the drug will operate at a capacity of up to 540 tons a year. How much the project owners have invested in the effort has yet to be unveiled. 

According to Natalia Tkachenko, the CEO of the Ural Nanotech Center, they see interest from a range of organizations located in other Russian regions, such as Moscow, Tyumen, Chelyabinsk and some others, as well as in foreign countries, including Germany, Israel, Brazil, some African states, and a few others. A registration procedure for the drug is currently under way and nearing completion in the EU, Egypt, and Uzbekistan, Ms. Tkachenko said.

Source

Return